US2019101546A1PendingUtilityA1

Methods of treating stroke

52
Assignee: BIOGEN MA INCPriority: May 25, 2006Filed: Oct 3, 2018Published: Apr 4, 2019
Est. expiryMay 25, 2026(expired)· nominal 20-yr term from priority
A61P 43/00A61P 9/10A61P 7/04A61P 9/00A61P 25/00A61P 25/28C07K 16/2842A61K 2039/505G01N 2800/2871A61K 31/00G01N 33/6896A61K 38/193A61K 38/49
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and compositions for treating stroke are disclosed.

Claims

exact text as granted — not AI-modified
1 .- 22 . (canceled) 
     
     
         23 . A method of treating spinal cord injury (SCI) in a subject, the method comprising administering to the subject a VLA-1 antagonist in an amount effective to treat SCI. 
     
     
         24 . A method of treating spinal cord injury (SCI) in a subject, the method comprising administering to the subject an anti-VLA-1 antibody, or an antigen-binding fragment thereof. 
     
     
         25 . The method of  claim 23 , wherein the SCI is selected from the group consisting of incomplete SCI, central cord syndrome, Brown-Sequard syndrome, anterior cord syndrome, conus medullaris syndrome and cauda equina syndrome. 
     
     
         26 . The method of  claim 24 , wherein the anti-VLA-1 antibody, or antigen-binding fragment thereof, is a human, chimeric or humanized anti-VLA-1 antibody, or an antigen-binding fragment thereof. 
     
     
         27 . (canceled) 
     
     
         28 . A method of treating ischemia-reperfusion injury in a subject, the method comprising administering to the subject a blocking VLA-1 antibody, or antigen-binding fragment thereof, in an amount effective to treat the injury.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.